NASDAQ | TSX: ACB EDMONTON, AB, Feb. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, is pleased to announce today that Simona King, a former executive of Bristol Myers-Squibb, a leading multinational pharmaceutical company, has been appointed as Chief Financial Officer of the Company, effective February 21, 2024. Ms. King brings over 25 years of progressive finance leadership experience, with deep ...

Top Marijuana Stocks For Investors 2024Investors are working on various strategies to see returns from their marijuana stock investments. As most who are active in the sector can see the upward momentum is not consistent. Much of the way cannabis stocks perform is based on volatility and other catalysts. For example, when there is news important enough to interest traders it often leads to a rise in trading. Still with a lot going on throughout the cannabis sector where is one to start when developing a tra ...

Recent developments underscore the turbulent scenario investors are grappling with in the cannabis sphere, shedding light on the cannabis stocks to sell. While the U.S Drug Enforcement Administration mulls over changing marijuana’s Schedule 1 status and the Health and Human Services leans towards relaxing federal restrictions, a sliver of hope emerges. In that scenario, it becomes imperative for investors to hitch their rides with solid stocks in the cannabis realm.Furthermore, environmental considerations ...

The S&P 500 is in a bull market, but some companies aren't keeping pace. On the one hand, stocks that get left behind during a bull run can be worth investing in, provided they have significant upside potential and their slump is temporary. But other times, companies fail to perform on par with broader equities for a good reason: Serious problems with their businesses are unlikely to be resolved anytime soon. That's the case with Aurora Cannabis (ACB 6.45%) and Peloton Interactive (PTON 0.44%). Here is why ...

Top Performer’s Surge in the Cannabis SectorIn February 2024, top Canadian cannabis stocks showed mixed performance amid evolving market dynamics. Companies like Canopy Growth, Aurora Cannabis, and Tilray Brands remained focal points for investors. Market movements were influenced by quarterly earnings reports, with some companies exceeding expectations and others falling short. This period saw significant attention to operational efficiencies and international expansion efforts. Additionally, updates on pr ...

Aurora Cannabis Inc. (ACB) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to loss of $0.14 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -100%. A quarter ago, it was expected that this company would post a loss of $0.05 per share when it actually produced a loss of $0.05, delivering no surprise.Over the last four quarters, the company has surpassed cons ...

Aurora Cannabis Inc. (NASDAQ:ACB) Q3 2024 Earnings Conference Call February 8, 2024 8:00 AM ET Company Participants Ananth Krishnan - VP, Corporate Development & Strategy Miguel Martin - CEO Glen Ibbott - CFO Conference Call Participants Frederico Gomes - ATB Capital Markets Matt Bottomley - Canaccord Tamy Chen - BMO Capital Markets Douglas Miehm - RBC Capital Markets Pablo Zuanic - Zuanic Associates Operator Greetings, and welcome to the Aurora Cannabis Third Quarter 2024 Results Conference Call. All parti ...

Aurora Cannabis (NASDAQ:ACB) stock is climbing higher on Thursday after completing its acquisition of MedReleaf Australia.Aurora Cannabis used a wholly-owned subsidiary to acquire the 90% stake in MedReleaf Australia that it didn’t already own. The deal is worth $50 million with Aurora Cannabis paying $9.45 million in cash and the remaining in ACB stock.The acquisition of MedReleaf Australia gives Aurora Cannabis a firm footing in the medical cannabis market in Australia. This market is valued at $400 milli ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Aurora Cannabis Inc (NASDAQ: ACB) is in focus today after buying the remaining 90% stake in MedReleaf Australia for about AU$50 million ($32.45 million).Details of Aurora-MedReleaf transactionCopy link to sectionThe licensed cannabis producer paid $9.45 million in cash and the remaining in stock. Aurora caught interest in buying MedReleaf because it’s currently the second largest player in medical cannabis in Australia. Miguel Martin – chief executive of the Edmonton-headquartered firm said in a press relea ...